FDA Adverse Event Malfunction Summary report: N

DEXTRUS 4135

MDR report key: 2895999 · Received November 19, 2012

Report

Report Number
1028232-2012-03002
Event Type
Malfunction
Date Received
November 19, 2012
Date of Event
September 12, 2012
Report Date
November 14, 2012
Manufacturer
BIOTRONIK SE & CO. KG
Product Code
NVZ
PMA / PMN Number
P950037
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
GM
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

(B)(6) 2018 - WE WERE NOTIFIED THAT THIS LEAD WAS EXPLANTED BUT NOT RETURNED FOR ANALYSIS.

Additional Manufacturer Narrative · 1

THE DEVICE WAS NOT RETURNED FOR ANALYSIS. THE ANALYSIS IS THEREFORE BASED ON THE INSPECTION OF THE QUALITY DOCUMENTS ACCOMPANYING THIS PARTICULAR DEVICE. THE MANUFACTURING PROCESS FOR THIS DEVICE WAS RE-INVESTIGATED. ALL PRODUCTION STEPS HAD BEEN PERFORMED ACCORDINGLY. THERE WAS NO SIGN OF ANY INCONSISTENCY DURING THE MANUFACTURING PROCESS, WHICH MIGHT BE RELATED TO THE CLINICAL OBSERVATION. IN SUMMARY, THE DEVICE WAS NOT RETURNED FOR ANALYSIS. THE REVIEW OF THE QUALITY DOCUMENTS CONFIRMED A REGULAR DEVICE MANUFACTURING.

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT DURING A ROUTINE DEVICE CHANGE OUT PROCEDURE, THIS RIGHT ATRIAL LEAD PACING IMPEDANCE MEASUREMENT WAS 1,200 OHMS. CURRENTLY, THE PACING IMPEDANCE MEASUREMENT WAS GREATER THAN 2,000 OHMS, WITH QUESTIONABLE ATRIAL CAPTURE. THE PATIENT WAS SENT FOR A CHEST X-RAY AND RESULTS WERE NOT AVAILABLE FROM THE PHYSICIAN. TO DATE, NO ADVERSE PATIENT EFFECTS WERE REPORTED AS A RESULT OF THIS CLINICAL OBSERVATION. AS NO FURTHER INFORMATION CONCERNING THIS REPORT IS EXPECTED, OUR INVESTIGATION IS COMPLETE. THIS INVESTIGATION WILL BE UPDATED SHOULD FURTHER INFORMATION BE PROVIDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 DEXTRUS 4135 PACING LEAD NVZ BIOTRONIK SE & CO. KG 358744

Patients

Seq Age Sex Outcome Treatment
1 UNK Other